Entering the healthcare business using plant-based ingredients
First written in FY2021-Q2. 2 of 3 entries say "Advanced", first in FY2022. Latest entry: FY2024-Q3.
No other company in this theme has enough history to compare yet.
- FY2024-Q3AdvancedAnnual report
「In November 2023, the company developed and began selling its first product in the plant biotechnology business, “鋼の肝臓KReTA.” By combining the functional properties of plants from the East Mikawa region with the strengths of the company's proprietary biotechnology, it aims to contribute to improving people's quality of life worldwide and further expand the business.」
Regarding the healthcare business using plant-based ingredients, the company progressed to the stage of developing its first plant biotechnology product and beginning sales in November 2023. - FY2022AdvancedAnnual report
「株式会社Waphyto Toyohashi, Aichi Prefecture Manufacture and sale of cosmetics containing plant-based ingredients, health foods and other products 49.0%」
Regarding the healthcare business using plant-based ingredients, the company positions Waphyto as an equity-method affiliate and holds 49.0% of its voting rights. - FY2021-Q2First statedAnnual report
「Entering the healthcare business, including cosmetics made with highly functional ingredients extracted from plants in East Mikawa」
The company has identified entry into the healthcare business, including cosmetics using plant-based ingredients from East Mikawa, as a new business area for development for the first time.